Pharma Journalist -

Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB, a biotech company focused on the…
Read More...

NiKang Therapeutics Inc. a clinical stage biotech company focused on developing innovative small molecule oncology medicines to help patients with unmet medical needs, announced the…
Read More...

We live in an era of increasing digital involvement. Audiences are inundated with more messages than ever before, and the competition for engagement is fierce. So how do you reach…
Read More...

Pieris Pharmaceuticals, Inc., a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases,…
Read More...

Ajinomoto Bio-Pharma Services announced it will soon open a high speed multi-purpose fill finish line in its state-of-the-art commercial manufacturing facility located in San Diego, CA.…
Read More...

Alloy Therapeutics and Pyxis Oncology announced the formation of a joint venture named Kyma Therapeutics to develop immune-modulating antibodies for novel targets in cancer and…
Read More...

Xeris Pharmaceuticals, Inc. and Strongbridge Biopharma plc announced that they have entered into a definitive agreement under which Xeris will acquire Strongbridge for stock and…
Read More...

Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for BI 425809 for the treatment of Cognitive Impairment…
Read More...

Shanghai Stock Exchange listed company HitGen Inc. (“HitGen”) announced that it has entered into a research collaboration agreement with Dorian Therapeutics, Inc. (“Dorian”), a private…
Read More...

Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted positive opinions for…
Read More...